Technical Analysis for ARVN - Arvinas, Inc.

Grade Last Price % Change Price Change
grade B 22.63 -0.61% -0.14
ARVN closed down 0.61 percent on Tuesday, April 23, 2019, on 85 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical ARVN trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction -0.61%
NR7 Range Contraction -0.61%
Wide Bands Range Expansion -0.61%
Overbought Stochastic Strength -0.61%
180 Bullish Setup Bullish Swing Setup -0.92%
Wide Bands Range Expansion -0.92%
Overbought Stochastic Strength -0.92%
Upper Bollinger Band Walk Strength 9.38%

Older signals for ARVN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Biopharmaceutical Biology Diseases Genetics Androgen Receptor Metabolism
Is ARVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Apr 22 54 Biggest Movers From Thursday
Apr 2 51 Stocks Moving In Tuesday's Mid-Day Session
Apr 2 Arvinas Strengthens Management Team with Internal Appointments of Andy Crew, Ph.D. as Chief Technology Officer and Ian Taylor, Ph.D. as Chief Scientific Officer
Apr 1 Arvinas: Early-Stage Research In An Exciting Field, Worthy Of Entry?
Mar 28 VJET, RH, SAIC and SPI among notable after hour movers
Mar 26 Arvinas beats by $0.08, beats on revenue
Mar 26 Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Mar 25 Arvinas Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of PROTAC™ Protein Degrader, ARV-110
Mar 23 Stocks To Watch: Apple Makes Its Video-Streaming Move
Mar 16 Did Arvinas Holding Company, LLC (NASDAQ:ARVN) Insiders Buy Up More Shares?
See more ARVN news...
Indicators
Indicator Value
52 Week High 25.6
52 Week Low 10.19
Average Volume 137,119
200-Day Moving Average 0.0
50-Day Moving Average 18.863
20-Day Moving Average 18.903
10-Day Moving Average 21.397
Average True Range 1.3901
ADX 30.65
+DI 29.8651
-DI 14.6602
Chandelier Exit (Long, 3 ATRs ) 19.1397
Chandelier Exit (Short, 3 ATRs ) 18.2353
Upper Bollinger Band 24.51
Lower Bollinger Band 13.296
Percent B (%b) 0.83
BandWidth 59.323917
MACD Line 1.4184
MACD Signal Line 0.9145
MACD Histogram 0.5039
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.13
Resistance 3 (R3) 24.07 23.52 23.88
Resistance 2 (R2) 23.52 23.13 23.55 23.80
Resistance 1 (R1) 23.07 22.90 22.80 23.13 23.71
Pivot Point 22.52 22.52 22.38 22.55 22.52
Support 1 (S1) 22.07 22.13 21.80 22.13 21.55
Support 2 (S2) 21.52 21.90 21.55 21.46
Support 3 (S3) 21.07 21.52 21.38
Support 4 (S4) 21.13